ConvaTec Group Provides Regulatory Update
The healthcare company has announced a regulatory filing regarding a change in shareholding.
The healthcare company has announced a regulatory filing regarding a change in shareholding.
The healthcare company has made a regulatory filing, but no further details are provided.
The healthcare company has filed a regulatory announcement, but no further details are provided.
The healthcare company welcomes the postponement of LCDs in the US, which will allow continued access to its InnovaMatrix product for Medicare patients.
The healthcare company has reported a change in major shareholding, with FIL Limited increasing its stake to over 6%.
The healthcare company has disclosed details of a PDMR's vesting of shares under the long-term incentive plan and subsequent sale of shares to cover tax liabilities.
The healthcare company announced the vesting of shares for its CEO under long-term incentive plans.
The medical products and technologies company announces changes to director and PDMR shareholdings through the grant of incentive awards.
The healthcare company has published its annual report and notice of annual general meeting, a routine regulatory update.
The medical products and technologies group reported strong FY24 results with 7.7% organic revenue growth and 13.7% increase in adjusted EPS. Management expressed confidence in the FY25 outlook, targeting continued growth and margin expansion.